STMN1 and breast cancer: Of note, low levels of Ser16-phosphorylated stathmin correlate with metastatic states of breast cancer [61], and an increase in Ser16 has been shown to reduce migration in esophageal cancer cells [62], thus underscoring its influence in limiting migration and possibly increasing adhesion.